Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Perrigo Company (PRGO)

Perrigo Company (PRGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,523,115
  • Shares Outstanding, K 136,313
  • Annual Sales, $ 4,837 M
  • Annual Income, $ 146,100 K
  • 60-Month Beta 1.20
  • Price/Sales 1.55
  • Price/Cash Flow 7.93
  • Price/Book 1.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.87
  • Number of Estimates 6
  • High Estimate 1.01
  • Low Estimate 0.70
  • Prior Year 0.86
  • Growth Rate Est. (year over year) +1.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.14 +10.07%
on 06/15/20
58.26 -5.27%
on 06/08/20
-1.19 (-2.11%)
since 06/02/20
3-Month
42.42 +30.10%
on 04/03/20
58.26 -5.27%
on 06/08/20
+12.39 (+28.95%)
since 04/02/20
52-Week
40.01 +37.94%
on 04/02/20
63.86 -13.58%
on 02/25/20
+5.81 (+11.77%)
since 07/02/19

Most Recent Stories

More News
Medical Products Industry's Near-Term Outlook Lacks Spark

Medical Products Industry's Near-Term Outlook Lacks Spark

ZBH : 120.61 (+1.06%)
SYK : 183.94 (+0.05%)
RMD : 192.48 (+0.85%)
PRGO : 55.19 (+0.66%)
MDT : 93.16 (+0.91%)
ISRG : 580.48 (+0.86%)
HRC : 111.57 (+1.00%)
BSX : 35.38 (+0.28%)
BAX : 87.21 (-0.11%)
ABT : 92.23 (+0.64%)
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin...

PRGO : 55.19 (+0.66%)
SLGL : 8.69 (-0.46%)
BHC : 18.34 (-0.43%)
Perrigo Announces The Closing Of A Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance Unlimited Company

, /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE; TASE: PRGO) today announced the closing of the previously announced registered public offering by Perrigo Finance Unlimited Company,...

PRGO : 55.19 (+0.66%)
Perrigo Furthers Its Consumer-Focused Transformation By Divesting Its U.K. Generic Prescription Pharmaceuticals Business For £156 Million Or Approximately $195 Million

, /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has reached a definitive agreement to sell its U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals...

PRGO : 55.19 (+0.66%)
Perrigo Partners With Kazmira LLC To Enter CBD Market Through A Two-Phased, Science-Based Approach

, /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, announced today that it is entering the cannabidiol ("CBD") market through...

PRGO : 55.19 (+0.66%)
Perrigo Announces The Pricing Of A Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance Unlimited Company

, /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE; TASE: PRGO), a leading global provider of  today announced the pricing of a previously announced registered public offering...

PRGO : 55.19 (+0.66%)
Perrigo Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary, Perrigo Finance Unlimited Company

, /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that Perrigo Finance Unlimited...

PRGO : 55.19 (+0.66%)
Glaucoma Drugs Market Opportunities, Demands and Growth Revenue by 2025 | Brandessence Market Research Report

AERI : 13.97 (-3.39%)
AGN : 193.02 (+0.02%)
CANF : 2.00 (+3.09%)
ITEK : 3.04 (-5.00%)
MRK : 78.78 (+0.84%)
NMUS : 0.6500 (-9.52%)
NVS : 87.57 (-0.32%)
OCAT : 8.47 (+0.12%)
OCUL : 7.98 (-3.27%)
OHRP : 5.39 (+30.19%)
PRGO : 55.19 (+0.66%)
PFE : 34.51 (+2.28%)
SNPHF : 18.6000 (+0.54%)
SCMP : 18.05 (+0.28%)
TEVA : 11.35 (-1.39%)
VRX.TO : 30.80 (-3.33%)
Global Infant Formula Market Analysis and Forecasts to 2024, Featuring Key Players Nestle Group, Danone, Perrigo Nutritionals and Hero Group

, /PRNewswire/ -- The report has been added to offering.

ABT : 92.23 (+0.64%)
DANOY : 14.0026 (+2.36%)
PRGO : 55.19 (+0.66%)
Keloid Treatment Market Analysis as per the Latest Coronavirus Impact

AVMXY : 7.8900 (+9.13%)
BMY : 59.14 (+0.27%)
GALE : 0.26 (-7.14%)
GSK : 41.22 (+0.88%)
NVS : 87.57 (-0.32%)
PRGO : 55.19 (+0.66%)
SNOA : 6.74 (-2.03%)
VRX.TO : 30.80 (-3.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade PRGO with:

Business Summary

Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United...

See More

Key Turning Points

2nd Resistance Point 57.29
1st Resistance Point 56.24
Last Price 55.19
1st Support Level 54.58
2nd Support Level 53.98

See More

52-Week High 63.86
Last Price 55.19
Fibonacci 61.8% 54.75
Fibonacci 50% 51.93
Fibonacci 38.2% 49.12
52-Week Low 40.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar